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Dietary exposure to prion-contaminatedmaterials has caused kuru and variant Creutzfeldt-Jakob disease in humans
and transmissible spongiformencephalopathies (TSEs) in cattle,mink, and felines. The epidemiology of dietary prion
infectionssuggests thathostgeneticmodifiersandpossiblyexogenouscofactorsmayplayadecisiverole indetermining
disease susceptibility. However, few cofactors influencing susceptibility to prion infection have been identified. In the
presentstudy,weinvestigatedwhethercolitismightrepresentonesuchcofactor.Wereportthatmoderatecolitiscaused
by an attenuated Salmonella strainmore than doubles the susceptibility of mice to oral prion infection andmodestly
accelerates the development of disease after prion challenge. The prion protein was up-regulated in intestines and
mesenteric lymphnodesofmicewithcolitis,providingapossiblemechanismfortheeffectofcolitisonthepathogenesis
of prion disease. Therefore,moderate intestinal inflammation at the time of prion exposuremay constitute one of the
elusive risk factors underlying the development of TSE.
Prion diseases are fatal neurodegenerative disorders of
mammals caused by the conformational conversion of
the cellular, glycosylphosphatidylinositol-linked prion
protein, known as PrPC, into a  sheet–rich, aggregated
isoform, known as PrPSc [1]. Prion infections can be in-
duced by oral challenge [2– 4] and occur naturally
as a result of foodborne contamination, as has been
shown for kuru, transmissible mink encephalopathy,
bovine spongiform encephalopathy (BSE), and variant
Creutzfeldt-Jakob disease (vCJD) [5– 8]. vCJD in hu-
mans is believed to have been caused by consumption of
beef products contaminated with BSE prions. Despite a
probable massive exposure of the European population
to the BSE agent, there have been 200 vCJD cases to
date [7]. This disproportionately low incidence of infec-
tion was very fortunate, yet it was unexpected by most
scientists and has led to speculation as to whether spe-
cific host risk factors are associated with the develop-
ment of vCJD [9, 10]. Among such risk factors may be
genetically determined, host-encoded modifiers. These
include the highly prevalent methionine/valine (Met/
Val) polymorphism at codon 129 of thePRNP gene [11],
given that to date all patients with confirmed vCJD have
been found to harbor homozygous Met/Met alleles.
However, this observation alone cannot explain the rar-
ity of vCJD, given that the prevalence of Met/Met in
humans is30%.
Nongenetic and extrinsic modifiers may plausibly
contribute to susceptibility. One risk factor for prion
infection may be an altered immune system. vCJD,
chronic wasting disease of cervids, scrapie, and other in-
fectious prions replicate in lymphoid tissues before in-
vading the central nervous system [3, 12–15]. Within
lymphoid germinal centers, follicular dendritic cells
have been demonstrated to play a key role in prion ac-
cumulation [16 –18], and their proximity to nerve end-
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ings influences the kinetics of prion neuroinvasion [19]. Accord-
ingly, modification of the lymphoid system can profoundly
influence the pathogenesis of prion disease. For example, mice
lacking the complement factor C1q, lymphotoxin-, lympho-
toxin-, or the lymphotoxin- receptor either resisted intraperito-
neal infection with limiting doses of scrapie prions [20, 21] or expe-
rienced a delayed infection [22]. Conversely, recruitment of
immune cells caused by chronic inflammation enables prion repli-
cation at atypical sites, such as parenchymal organs [23, 24].
After ingestion, the gastrointestinal mucosa affords only lim-
ited physical protection against prion infection. Prions have
been found to cross mucosal barriers in vitro through membra-
nous epithelial cells (M cells), which are specialized sites of an-
tigen sampling for mucosa-associated lymphoid tissue [25]. Sev-
eral reports have also indicated that prion transport may occur
through enterocytes [26, 27] and may be internalized via laminin
receptor binding and endocytosis [28]. The number of Peyer
patches (PPs) has been shown to influence susceptibility to prion
infection, with a decrease in PPs associated with reduced suscep-
tibility in mice exposed orally to scrapie prions [15]. Within 2
weeks of prion ingestion, prions appear to enter peripheral
nerves [13] and proceed by invasion of the dorsal motor nucleus
of the vagus in the brain, as has been shown in mouse and ham-
ster scrapie studies [29].
Could inflammatory lesions at the mucosal entry site alter
susceptibility to prion infection? Inflammatory bowel disease
may compromise epithelial tight junctions [30, 31], activate
dendritic cells [16], enhance protein antigen uptake [32], and,
most crucially, redirect prion replication to the inflamed sites
[23, 24]. Hence, intestinal inflammation could conceivably alter
the dynamics of prion entry and systemic spread. Gastrointesti-
nal infections caused by viruses, bacteria, and parasites, as well as
idiopathic inflammatory diseases, are common in animals and
humans, and their contribution to susceptibility to prion infec-
tion has not been established.
In the present study, we investigated whether preexisting
acute intestinal inflammation alters the susceptibility or kinetics
of prion infection. We used a well-established mouse model for
Salmonella enterocolitis combined with an attenuated Salmo-
nella enterica subspecies 1 serovar Typhimurium mutant
(M556). S. Typhimurium M556 induces a moderate acute sup-
purative inflammation restricted largely to the cecum and colon
within 24 h [33, 34]. Three days after M556 inoculation, we
administered scrapie prions by gastric gavage. We found that
mice with intestinal inflammation had a significantly higher risk
of prion disease.
METHODS
S. Typhimurium and prion infections in mice. Sex- and
age-matched specific pathogen–free C57BL/6 mice (groups of
8 –12) were maintained under matched specific pathogen–free
conditions. All mouse experiments were approved by the Swiss
veterinary authorities. For S. Typhimurium infections and con-
trols, mice were transferred into new cages with a metal grid
floor, fasted for 4 h, and then treated with 20 mg of streptomycin
intragastrically. Twenty hours later, mice were fasted and then
orally administered, by gastric gavage, either a mutant strain
of S. Typhimurium SL1344 (M556; deficient in the TTSS-2
type 3 secretion system; sseD::aphT [34]) in 50 L containing
4.3  107 S. Typhimurium organisms or PBS. A third group
was not administered streptomycin or S. Typhimurium.
Three days later, mice were fasted and orally challenged with
6.4 – 8.4 log LD50 infectious doses of the RML6 scrapie strain by
gastric gavage. A group of control mice was administered S. Ty-
phimurium orally, as described above, and then administered
uninfected brain homogenate (mock challenge). The cages were
changed before each procedure. Fecal samples were collected
after infection, homogenized in 500 L of PBS, diluted, and
plated onto MacConkey agar, and S. Typhimurium colonies
were counted 24 – 48 h later.
Mice were weighed, and a blood sample was collected 43 days
after scrapie challenge. Two mice in each group were euthanized
at 60 and 120 days after scrapie challenge. The intestines were
washed in PBS, and separate sections were fixed in formalin,
embedded in OCT medium, and snap-frozen in liquid nitrogen
for later cryosectioning. Mesenteric lymph nodes (MLNs),
spleen, spinal cord, and brain were similarly fixed in formalin
and frozen. Tissues from all major organs were fixed in formalin
for histological examination. Samples from mice with terminal
scrapie were collected similarly.
For the final experiment to measure PrPC levels, mice were
inoculated with S. Typhimurium or PBS, as described above.
Cecum was embedded in OCT medium and snap-frozen in liq-
uid nitrogen. Cryosections were stained with hematoxylin-eosin
(HE). Cecum pathology was evaluated by a pathologist in a
blinded manner using a histopathological scoring scheme, as
described elsewhere [34, 35].
RNA isolation and real-time polymerase chain reaction
(PCR) analysis. Flash-frozen tissues (MLNs) were dissolved
in RNA isolation buffer (RLT; Qiagen) and homogenized in a
Dispomix device (Medic Tools). RNA was purified as described
in the manufacturer’s manual (Qiagen). cDNA was generated
with a QuantiTect Reverse Transcription Kit, and real-time PCR
analysis was performed as described elsewhere, using a Quanti-
Fast SYBR Green PCR Kit [23, 24]. The following primer com-
binations were used for forward (FW) and reverse (RV) primers:
prnp FW, 5'-GCCAGTGGATCAGTACAGCA-3'; prnpRV, 5'-A-
TCCCACGATCAGGAAGATG-3'.
Statistics. Continuous data are presented as means  SDs
and were compared using Student’s unpaired t test. The time to
manifestation of terminal scrapie was analyzed within experi-
ments by means of Kaplan-Meier curves. S. Typhimurium–in-
fected mice were compared with control mice by the log-rank
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test. A stratified Cox regression analysis was performed to com-
pare times to manifestation of scrapie between groups for the
pooled data for all 3 experimental doses. Differences were con-
sidered statistically significant at P  .05 (2-tailed). Statistical
analyses were performed using GraphPad Prism (version 4.0)
and SPSS (version 13.0) software.
Western blots, histology, immunohistochemistry, and ELISAs.
Western blot, histology, immunohistochemistry, and ELISA meth-
ods are included in appendix A, which appears only in the electronic
edition of the Journal.
RESULTS
S. serovar Typhimurium colitis. We pretreated 2 groups of
C57BL/6 wild-type mice with streptomycin, which transiently
reduces the density of the commensal gut flora [36] and enables
S. Typhimurium to colonize the cecum and colon of mice and
cause localized inflammation within 3 days [33, 37]. The atten-
uated S. Typhimurium strain M556 triggers acute colitis but
lacks a key virulence factor for systemic infection in “suscepti-
ble” Nramp-negative mouse lines (e.g., C57BL/6). Twenty-four
hours later, we gastrically gavaged mice with either PBS or en-
teropathogenic mutant S. Typhimurium deficient in SPI-2 type
3 secretion (12 mice/group). Untreated mice were included as a
third group. Three days later, 2 mice per group were euthanized
to assess intestinal and systemic pathology, and the remaining
mice were exposed to 8.4 log LD50 murine-adapted scrapie brain
homogenate (Rocky Mountain Laboratory strain RML6) by gas-
tric gavage. In addition, a control group of 8 mice was pretreated
with streptomycin, administered the same S.Typhimurium mu-
tant, and gastrically gavaged with normal mouse brain homog-
enate.
Fecal samples collected during the initial 3 weeks after chal-
lenge showed that all S. Typhimurium–inoculated groups were
colonized. Fecal S.Typhimurium counts decreased steadily after
the challenge (figure 1A). S. Typhimurium–inoculated mice eu-
thanized at the time of exposure to scrapie prions had a moder-
ate colitis characterized by a neutrophil influx into the mucosa
and submucosa, crypt abscesses, crypt herniation, lymphocyte-
lined lymphatics, submucosal edema, and fibrin exudate on the
mucosal surface (compare figure 1B, 1D, and 1Ewith figure 1C).
There were a few additional scattered microabscesses in the liver
and spleen. Therefore, the S. Typhimurium transiently colo-
nized the intestine and led to inflammation in the cecum and
colon, similar to previous findings [36, 38].
To determine whether the lymphoid microarchitecture was
disrupted by S. Typhimurium infection, we performed an im-
munohistochemical analysis of the MLNs for B cells, T cells,
macrophages, dendritic cells, and follicular dendritic cells (fig-
ure 2). We did not detect any gross differences in the composi-
tion of the immune cell populations or in the number of germi-
nal centers. Therefore, inflammatory lesions were largely
localized to the cecum and colon.
Mice did not develop diarrhea or other clinical signs of disease
but instead grew normally over the subsequent 3 months, with
no difference in weight among groups and with normal total
blood leukocyte and differential leukocyte counts (figure 3A–
3E). Mice had normal serum amyloid A levels at 6 weeks after
infection (data not shown). From this we concluded that the S.
Typhimurium infection was acute, that S. Typhimurium was
rapidly cleared by 11–25 days after infection, and that mice did
not appear to have chronic intestinal inflammatory disease.
In the high-dose (HD) groups exposed to 8.4 log LD50, all mice
developed scrapie (table 1). Prion infectivity in the source inoc-
ulum was verified by the presence of intraperitoneal and intra-
cerebral control prion infections (table 1).
Figure 1. Development of colitis in C57BL/6 mice gavaged intragas-
trically with Salmonella serovar Typhimurium. A, S. Typhimurium coloni-
zation in feces, assessed as indicated. In 2 independent experiments, the
mean concentration of S. Typhimurium organisms was rapidly reduced to
2 log colony-forming units per gram of feces by 25 days after infection.
B, Colon histopathology at 3 days after S. Typhimurium challenge. Results
show a widespread influx of neutrophils and some lymphocytes into the
lamina propria. Neutrophils were associated with endothelium within
vessel lumina (asterisk) and adhered to the mucosal surface (arrows).
There was crypt herniation (arrowhead) and a loss of goblet cells. C,
Normal colon from a PBS-treated control mouse. D, Fibrin and suppura-
tive exudate on the colonic mucosal surface (asterisk). E, Crypt abscesses
(arrow) and pools of inflammatory cells in the mucosa (arrowhead). Scale
bars represent 100 m.
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Increase in susceptibility to prions due to concurrent
infection. We suspected that subtle differences in the kinetics
of prion infection may be masked by a high, saturating dose of
prions. Therefore, the experiment was repeated with 7.4 and 6.4
log LD50 of RML6 prions (medium-dose [MD] and low-dose
[LD] groups, respectively). We then determined whether, at
these lower doses, intestinal inflammation had an influence on
the number of mice with terminal prion disease, as assessed by
clinical signs and the detectability of PrPSc in the brain by West-
ern blot (attack rate). We found that the attack rate of scrapie
was influenced by coinfection with S. Typhimurium. We pooled
all control mice without S. Typhimurium infection for the sta-
tistical analyses. This procedure enabled us to formally assess the
effect of S. Typhimurium coinfection on the pathogenesis of
prion infection. Because of the small number of animals in the
subgroups, however, this comparison did not reveal any poten-
tial effects of isolated streptomycin treatment. In the MD group,
scrapie developed in 4 (67%) of 6 mice with S. Typhimurium
coinfection versus only 5 (45%) of 11 without coinfection. The
comparable numbers in the LD group were 1 (17%) of 6 versus 1
(9%) of 11 (table 1).
We then performed a survival analysis of the time from the
inoculation with prions to the manifestation of terminal scrapie
signs (survival time) (figure 4). In the HD groups, the median
SE survival time was 224 4 days for mice with and 230 0.5
days for mice without S. Typhimurium infection. By 275 days
after inoculation, no mice were free of scrapie. By comparison,
in the MD groups, the median  SE survival time was 216  5
days for mice infected with S. Typhimurium, whereas so few
mice developed disease that the median was not reached for mice
without S. Typhimurium coinfection. By 275 days after inocula-
tion, only 33% of S. Typhimurium–infected mice were free of
scrapie, with no PrPSc detectable in the brain by Western blot
or immunohistochemistry, but 55% of mice without S. Ty-
phimurium coinfection were free of scrapie. At the lowest
prion dose, 83% and 91% were free of scrapie in the
S. Typhimurium–infected and non–S. Typhimurium–infected
groups, respectively.
We next compared the attack rate in the HD, MD, and LD
groups by stratified Cox regression. We found a significant dif-
ference in the risk of terminal prion disease associated with S.
Typhimurium coinfection (P  .037). The hazard for contract-
ing scrapie was increased by 2.3-fold with S. Typhimurium in-
fection (95% confidence interval, 1.1–5.1-fold).
Modest acceleration of the pathogenesis of scrapie due to
colitis. To determine whether the kinetics of prion infection
differed depending on intestinal inflammation, we euthanized
mice at 2 time points preceding the development of clinical dis-
ease: 60 and 120 days after inoculation. We compared the accu-
mulation of prions in the MLNs and spleen among the HD
groups. PrPSc was detected by histoblot analysis in MLNs of all
scrapie-challenged mice at 60 days after inoculation (figure 5A),
a finding in accordance with the 100% attack rate in the HD
group.
However, the kinetics of prion disease varied among the MD
groups. By 60 days after inoculation, PrPSc was detected in MLNs
by Western blot in both of 2 mice exposed to S. Typhimurium
and in 2 of 4 mice exposed only to prions, suggesting accelerated
Figure 2. Immunohistochemical stains of mesenteric lymph nodes
(MLNs) from mice infected with Salmonella serovar Typhimurium. Infec-
tion was confirmed by fecal bacterial counts. Immunostains for B and
plasmacytoid dendritic cells (B220) and T cells (CD3) showed that B and
T cells were distributed in cortical (arrows) and paracortical (arrows)
areas, respectively, in both the S. Typhimurium–infected and non–S.
Typhimurium–infected mice. Macrophages (F4/80) (arrows) and dendritic
cells (CD11c) were primarily localized to the subcapsular sinus and
medullary cords, and follicular dendritic cells (FDC-M1) were present in
the follicular germinal centers in the cortex (arrows), indicating that the
overall histological state of the MLNs was not dramatically affected by
S. Typhimurium infection. S. Tm, S. Typhimurium.
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prion spread due to mucosal inflammation (figure 5B). In the
spleen, both of 2 S. Typhimurium– coexposed mice had detect-
able PrPSc, compared with only 1 of 4 mice without S. Typhi-
murium infection (figure 5C). We quantified the intensity of the
Western blot signals among the MLNs and spleens and found
significantly higher PrPSc levels in mice with S. Typhimurium
coinfection (P  .02 and P  .006, respectively, unpaired Stu-
dent’s t test). Histoblots of MLNs and spleen showed the same
results (figure 5C and 5D). By 120 days after inoculation, nearly
all mice had accumulated PrPSc in the MLNs and spleen, except
for 1 mouse that was administered prions only (figure 5B and
5C). Overall, these results suggest a trend toward accelerated
prion disease associated with concomitant colitis.
For the LD scrapie groups, PrPSc was detected in the MLNs in
1 of 2 mice coexposed to S. Typhimurium at 60 days after inoc-
ulation. None of the other mice receiving a low dose of prions
had detectable PrPSc in the MLNs (0/4 mice; data not shown).
The S. Typhimurium– exposed mice in the MD and LD groups
consistently showed detectable PrPSc in the MLNs and spleen
more frequently than non–S. Typhimurium– exposed mice. It is
possible that mice without detectable PrPSc in the MLNs or
spleen would never have developed scrapie, and the S. Typhi-
murium–induced inflammation may have led either to acceler-
ated scrapie or to an increase in susceptibility to scrapie at these
limiting doses of prions.
Increase in PrPC expression in cecum and MLNs due to
Salmonella infection. The accelerated kinetics associated with
coinfection may have been due to increased PrPC expression
caused by inflammation. To determine whether the S. Typhi-
murium infection led to PrPC up-regulation, we gavaged groups
Figure 3. Normal body weight and unchanged complete blood counts in mice infected with Salmonella serovar Typhimurium M556. A, Body weight
of S. Typhimurium–infected and control mice 43 days after prion exposure (P  .14, Student’s unpaired 2-tailed t test). B, Total leukocyte counts. Counts
showed no significant difference between the S. Typhimurium–infected and control mice (P  .08). C–E, Differential counts of neutrophils, lymphocytes,
and monocytes. These counts also showed no or slightly significant differences between S. Typhimurium–infected and control mice (P  .04, P  .06,
and P  .26, respectively). S. Tm, S. Typhimurium.
Table 1. Incubation periods in RML6 prion–infected mice at 3 doses.
Colon condition
Oral infection
8.4 log LD50 7.4 log LD50 6.4 log LD50
Attack ratea
Incubation
period, daysb Attack ratea
Incubation
period, daysb Attack ratea
Incubation
period, daysb
Inflammation 6/6 (100) 225 2 4/6 (67) 215 3 1/6 (17) 213 (560 for 5 mice)
No inflammation 12/12 (100) 232 2 5/11 (45)c 236  12 1/11 (9)c 218 (560 for 10 mice)
a Data are no. of mice with terminal scrapie/total no. of mice (%).
b Data are the no. of days between prion inoculation and the development of clinical signs of terminal scrapie, given as means  SEs
for diseased animals (except for the lowest dose, because only 1 mouse was diseased for each condition).
c One mouse in each group died of causes unrelated to scrapie and was not included in the calculation of the incubation period.
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of 6 C57BL/6 mice with either S. Typhimurium or PBS, quanti-
fied the S.Typhimurium colonization, confirmed the colitis with
histological sections of intestine (figure 6A– 6C), and measured
PrPC expression in the cecum, MLNs, and spleen by ELISA. We
found that PrPC levels were significantly increased by the S. Ty-
phimurium infection in the cecum (3-fold; P  .001, unpaired
Student’s t test) and MLNs (1.5-fold; P  .013), but not in the
spleen (figure 6D). Among the control mice, PrPC expression
levels were 10-fold higher in the MLNs than in the spleen.
Prion mRNA levels were assessed for MLNs and were also found
to be significantly elevated in S. Typhimurium–infected mice,
compared with those in uninfected mice (2-fold; P  .007)
(figure 6E). Thus, acute mucosal inflammation increases the
PrPC concentration in the affected tissue. This may translate into
an elevated susceptibility to prion infection.
DISCUSSION
We found that moderate acute intestinal inflammation leads to
an enhanced risk of contracting prion disease on oral exposure.
After exposure to limiting dilutions of prions, the risk of prion
infection more than doubled with concurrent intestinal inflam-
mation. This increase in susceptibility to prion infection associ-
ated with colitis was accompanied by only a slight acceleration in
the kinetics of infection. The S. Typhimurium infection caused
an acute yet relatively mild inflammation localized to the distal
gastrointestinal tract, with no visible clinical signs of disease in
the mice. This model is physiologically similar to mild forms of
acute inflammatory colitis in humans and other animals [39].
Therefore, these results suggest that colitis at the time of expo-
sure to prions may be a realistic exogenous risk factor for prion
infection.
Several mechanisms may plausibly underlie the enhanced sus-
ceptibility to prion infection. In the S. Typhimurium–infected
mice, PrPC expression was increased 3-fold in the cecum and
1.5-fold in the draining MLNs, consistent with increased
PrPC expression detected in the stomachs of humans with
Helicobacter-induced gastritis [40]. Because PrPC expression di-
rectly correlates with incubation period (or the time from prion
inoculation to development of terminal scrapie [41]), the ele-
vated PrPC expression in the cecum may lead to increased prion
conversion and accelerated prion transport and neuroinvasion.
A second possible mechanism is that prion uptake is increased
through a disrupted epithelial barrier, which has been shown to
enhance protein uptake in Crohn disease [32]. This would effec-
tively increase the systemic dose of prions. A third mechanism
may involve increased trafficking of prions to draining lymphoid
follicles in migrating S. Typhimurium– containing dendritic
cells [42– 44].
The finding of an eroded mucosa associated with an enhanced
risk for prion disease is consistent with other reports. Laceration
of the tongue had a marked effect on susceptibility to lingually
applied prions [45], with the incidence of prion disease reaching
100% versus 29% in mice with intact tongues. Another study
found that scarification of the oral cavity followed by prion ex-
posure showed a similar trend, with 100% of scarified mice ver-
sus 71% of nonscarified mice becoming infected with prions
[46]. These results might suggest that the enhanced susceptibil-
ity to prion disease in all 3 models is due to a breach in the
mucosal barrier or enhanced epithelial permeability, allowing
increased prion uptake.
Prion infection after oral exposure requires PPs in mice, and
any numerical decrease in PPs reduces the risk of prion infection
[15]. However, a recent study found that reducing the number of
PPs had no effect on scrapie infection, provided that numerous
isolated lymphoid follicles containing follicular dendritic cells
were present [47]. Another study examined the correlation be-
tween the PP surface area, follicle density, PP weight, or number
of PPs and the risk of prion infection in sheep, cattle, and hu-
mans. A significant correlation was found in all 3 prion host
species, suggesting a link between PP development and natural
susceptibility to transmissible spongiform encephalopathy [48].
In our experiments, acute S. Typhimurium infection did not
Figure 4. Survival curves for mice infected with Salmonella enterica serovar Typhimurium and control mice challenged with 3 doses of prions. Only
mice receiving the highest dose of prions showed an attack rate of 100%. The incubation period from prion challenge to the development of terminal
scrapie was significantly shorter in S. Typhimurium–infected mice than in control mice. DPI, days post inoculation; S. Tm, S. Typhimurium.
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Figure 5. PrPSc in mesenteric lymph nodes (MLNs) and spleens of mice during early prion infection. A, Histoblots from mice infected with Salmonella
enterica serovar Typhimurium and from control mice. All histoblots showed PrPSc in MLNs by 60 days after inoculation (arrows), indicating that no
difference was seen in MLNs at this time point with the highest prion dose. B, Western blot analysis of MLNs from mice infected with a limiting dose
of prions at 60 and 120 days after inoculation. Blots indicated that some mice had no detectable PrPSc, probably owing to either slow or absent prion
infection. PK, proteinase K treatment of tissue homogenates. C, Splenic PrPSc levels from the same mice as in panel B. Levels were less than those
for MLNs at the same time points. D, Histoblots illustrating black PrPSc deposition in the spleen from the S. Typhimurium–infected mouse at 60 days
after inoculation (arrows) but not in the 2 non–S. Typhimurium–infected mice as well as in the S. Typhimurium–infected and streptomycin-treated mouse
(arrows) but not in the second non–S. Typhimurium–infected mouse at 120 days after inoculation. These findings are indicative of either delayed or
absent prion infection. dpi, days post inoculation; S. Tm, S. Typhimurium.
increase the size or number of PPs, suggesting that the latter are
not limiting or do not contribute to the increased risk of prion
disease with S. Typhimurium infection.
Previous studies have shown that lymphofollicular inflamma-
tory foci in nonlymphoid organs, including the liver, kidney,
mammary gland, and pancreas, can accumulate PrPSc[23, 49].
However, in contrast to the results shown here, the inflamma-
tion did not affect the susceptibility to or the kinetics of scrapie
prion infection [23]. These differences are not surprising, con-
sidering that, in the present study, inflammation occurred at a
mucosal surface, where prion uptake would take place. An array
of very common inflammatory lesions may therefore alter the
quantity of prions crossing the mucosal barrier, including buccal
erosions, glossitis, erosive tonsillitis, gastric ulcers, and enteritis.
All of these conditions, therefore, are likely to increase the like-
lihood of infection on exposure to prions.
Extensive epidemiologic investigations of vCJD cases have
been performed in the United Kingdom to identify risk factors
for the development of disease, including interviews with pa-
tients’ relatives and reviews of dental records [9, 10]. As might be
expected, frequent consumption of beef products likely to con-
tain mechanically recovered meat or head meat, which may have
been contaminated with central nervous tissue, has been associ-
ated with an increased risk of vCJD [9]. Other than the latter, few
exogenous risk factors have correlated with the development of
vCJD. On the other hand, it may be challenging to recognize any
risk posed by small lesions along the gastrointestinal tract, be-
cause (1) lesions may have occurred years before the onset of
prion disease, (2) mild gastrointestinal disease is extremely com-
mon, and (3) many cases are not treated by physicians and,
therefore, would not be reported. However, considering the re-
sults of the present study as well as the frequency of gastrointes-
Figure 6. Streptomycin-pretreated wild-type C57BL/6 mice 3 days after challenge with Salmonella enterica serovar Typhimurium M556 (sseD::aphT;
5  107 cfu administered intragastrically [34]) (n  6) or after mock challenge with PBS (n  6). A, Cecal S. Typhimurium loads. Mice were euthanized,
and cecal S. Typhimurium loads were determined by plating on MacConkey agar containing 50 g/mL streptomycin. The dotted line indicates the limit
of detection, and the black bar indicates the median. B, Cecal pathology. Cecal tissues were embedded, and inflammation (or lack thereof) was confirmed
by histopathological evaluation of hematoxylin-eosin–stained tissue sections; tissues were scored with respect to submucosal edema, neutrophil
infiltration, loss of goblet cells, and epithelial disruption. C, Representative images. Left, mock infected; right, S. Typhimurium infected. Scale bars
represent 200 m. Lower images show enlargements of areas indicated by boxes in the upper images. D, PrPC ELISA measurements in the cecum,
mesenteric lymph nodes (MLNs), and spleen from mice infected with S. Typhimurium and control mice. PrPC levels were elevated in the cecum and MLNs
but not in the spleen, owing to the SPI-2 mutant S. Typhimurium infection. E, Levels of prnp mRNA in MLNs. Levels were elevated 2-fold in S.
Typhimurium–infected mice, compared with those in control mice. S. Tm, S. Typhimurium.
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tinal tract erosions and ulcerations caused by infectious and
noninfectious diseases, gastrointestinal tract pathology may
plausibly exert a marked effect on susceptibility to prion disease
in humans and animals.
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